1. Home
  2. RGP vs MXCT Comparison

RGP vs MXCT Comparison

Compare RGP & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Resources Connection Inc.

RGP

Resources Connection Inc.

HOLD

Current Price

$4.71

Market Cap

138.0M

ML Signal

HOLD

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$1.15

Market Cap

129.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGP
MXCT
Founded
1996
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
138.0M
129.6M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
RGP
MXCT
Price
$4.71
$1.15
Analyst Decision
Strong Buy
Buy
Analyst Count
1
4
Target Price
$7.00
$5.50
AVG Volume (30 Days)
313.6K
1.3M
Earning Date
04-08-2026
05-12-2026
Dividend Yield
6.85%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$551,331,000.00
$33,026,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$18.50
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.06
$0.64
52 Week High
$6.07
$2.37

Technical Indicators

Market Signals
Indicator
RGP
MXCT
Relative Strength Index (RSI) 61.95 58.04
Support Level $4.21 $0.77
Resistance Level $4.82 $1.16
Average True Range (ATR) 0.22 0.08
MACD 0.01 -0.01
Stochastic Oscillator 89.92 55.38

Price Performance

Historical Comparison
RGP
MXCT

About RGP Resources Connection Inc.

Resources Connection Inc provides consulting and business initiative support services predominantly through its operative subsidiary, Resources Global Professionals. It has two segments RGP ( Resources Global Professionals.) and Sitrick. The RGP segment is focused on delivering consulting services catering to its client's operational needs and change initiatives utilizing a combination of bench and on-demand, talent. The Sitrick segment provides corporate, financial, transactional, and crisis communication and management services. The company generates a majority of its revenue from the RGP segment. Geographically, it derives its key revenue from North America and the rest from Europe and the Asia Pacific region.

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

Share on Social Networks: